Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Experience of lung transplantation in patients with lymphangioleiomyomatosis at a Brazilian Reference Centre (2017)

  • Authors:
  • USP affiliated authors: SAMANO, MARCOS NAOYUKI - FM ; CARVALHO, CARLOS ROBERTO RIBEIRO DE - FM
  • USP Schools: FM; FM
  • DOI: 10.1007/s00408-017-0045-y
  • Subjects: TRANSPLANTE DE FÍGADO; DOENÇAS PULMONARES INTERSTICIAIS; NEOPLASIAS PULMONARES; MORTALIDADE
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Lung
    • ISSN: 0341-2040
    • Volume/Número/Paginação/Ano: v.195, n.6, p.699-705, 2017
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00408-017-0045-y (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s00408-017-0045-y (Fonte: Unpaywall API)

    Título do periódico: Lung

    ISSN: 0341-2040,1432-1750



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Lung

    ISSN: 0341-2040

    Citescore - 2017: 1.85

    SJR - 2017: 0.79

    SNIP - 2017: 0.831


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2879698-10BCSEP 507 2017
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BALDI, Bruno Guedes; BALDI, Bruno Guedes; SAMANO, Marcos Naoyuki; et al. Experience of lung transplantation in patients with lymphangioleiomyomatosis at a Brazilian Reference Centre. Lung, New York, 2017, v. 195, n. 6, p. 699-705, 2017. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/24227 > DOI: 10.1007/s00408-017-0045-y.
    • APA

      Baldi, B. G., Baldi, B. G., Samano, M. N., Campos, S. V., Oliveira, M. R. de, Afonso Junior, J. E., et al. (2017). Experience of lung transplantation in patients with lymphangioleiomyomatosis at a Brazilian Reference Centre. Lung, 195( 6), 699-705. doi:10.1007/s00408-017-0045-y
    • NLM

      Baldi BG, Baldi BG, Samano MN, Campos SV, Oliveira MR de, Afonso Junior JE, Carraro RM, Teixeira RHOB, Minguini IP, Burlina R, Pato EZS, Carvalho CRR, Costa AN. Experience of lung transplantation in patients with lymphangioleiomyomatosis at a Brazilian Reference Centre [Internet]. Lung. 2017 ;195( 6): 699-705.Available from: http://observatorio.fm.usp.br/handle/OPI/24227
    • Vancouver

      Baldi BG, Baldi BG, Samano MN, Campos SV, Oliveira MR de, Afonso Junior JE, Carraro RM, Teixeira RHOB, Minguini IP, Burlina R, Pato EZS, Carvalho CRR, Costa AN. Experience of lung transplantation in patients with lymphangioleiomyomatosis at a Brazilian Reference Centre [Internet]. Lung. 2017 ;195( 6): 699-705.Available from: http://observatorio.fm.usp.br/handle/OPI/24227

    Referências citadas na obra
    Johnson SR, Cordier JF, Lazor R et al, Review Panel of the ERS LAM Task Force (2010) European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35(1):14–26
    McCormack FX, Gupta N, Finlay GR et al, ATS/JRS Committee on Lymphangioleiomyomatosis (2016) Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med 194(6):748–761
    Baldi BG, Freitas CS, Araujo MS et al (2014) Clinical course and characterization of lymphangioleiomyomatosis in a Brazilian reference centre. Sarcoidosis Vasc Diffuse Lung Dis 31(2):129–135
    Johnson SR, Whale CI, Hubbard RB, Lewis SA, Tattersfield AE (2004) Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 59(9):800–803
    McCormack FX, Inoue Y, Moss J et al (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364(17):1595–1606
    Freitas CS, Baldi BG, Araujo MS, Heiden GI, Kairalla RA, Carvalho CR (2015) Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations. J Bras Pneumol 41(3):275–280
    Yusen RD, Edwards LB, Dipchand AI et al, for the International Society for Heart and Lung Transplantation (2016) The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult lung and heart-lung transplant report—2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant 35(10):1170–1184
    Ando K, Okada Y, Akiba M et al (2016) Lung transplantation for lymphangioleiomyomatosis in Japan. PLoS ONE 11(1):e0146749
    Reynaud-Gaubert M, Mornex JF, Mal H et al (2008) Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation 86(4):515–520
    Ussavarungsi K, Hu X, Scott JP et al (2015) Mayo Clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis. Respir Med 109(10):1354–1359
    Machuca TN, Losso MJ, Camargo SM et al (2011) Lung transplantation for lymphangioleiomyomatosis: single-center Brazilian experience with no chylothorax. Transplant Proc 43(1):236–238
    Nakagiri T, Shintani Y, Minami M et al (2015) Lung transplantation for lymphangioleiomyomatosis in a single Japanese Institute, with a focus on late-onset complications. Transplant Proc 47(6):1977–1982
    Pechet TT, Meyers BF, Guthrie TJ et al (2004) Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 23(3):301–308
    Benden C, Rea F, Behr J et al (2009) Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 28:1–7
    Fine NM, Kushwaha SS (2016) Recent advances in mammalian target of rapamycin inhibitor use in heart and lung transplantation. Transplantation 100(12):2558–2568
    Costa AN, Baldi BG, de Oliveira Braga Teixeira RH, de Samano MN, de Carvalho CR (2015) Can patients maintain their use of everolimus until lung transplantation? Transplantation 99(6):e42–e43
    Simonneau G, Gatzoulis MA, Adatia I et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41
    Miller MR, Hankinson J, Brusasco V et al, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338
    Wanger J, Clausen JL, Coates A et al, ATS/ERS Task Force (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522
    Macintyre N, Crapo RO, Viegi G et al, ATS/ERS Task Force (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735
    Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33:397–406
    Neder JA, Andreoni S, Castelo-Filho A et al (1999) Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res 32:703–717
    Neder JA, Andreoni S, Peres C et al (1999) Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res 32:729–737
    Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968
    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
    Yusen RD, Edwards LB, Kucheryavaya AY et al, for the International Society for Heart and Lung Transplantation (2015) The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report—2015; focus theme: early graft failure. J Heart Lung Transplant 34(10):1264–1277
    Freitas CS, Baldi BG, Jardim C et al (2017) Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method. Orphanet J Rare Dis 12(1):74
    Bhorade S, Ahya VN, Baz MA et al (2011) Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med 183(3):379–387
    Groetzner J, Wittwer T, Kaczmarek I et al (2006) Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation. Transplantation 81(3):355–360
    Ghassemieh B, Ahya VN, Baz MA et al (2013) Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation. J Heart Lung Transplant 32(7):701–706
    Chen F, Omasa M, Kondo N et al (2009) Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation. Ann Thorac Surg 87(1):e6–e7
    Groetzener J, Kur F, Spelsberg F et al (2004) Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 23(5):632–638
    King-Biggs MB, Dunitz JM, Park SJ et al (2003) Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 75(9):1437–1443